Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System
Emily Nickoloff-Bybel, Tina M. Calderon, Peter J. Gaskill, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 4, pp. 729-742
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 156
Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders
Elena Irollo, Jared Luchetta, Chun-Ta Ho, et al.
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 9, pp. 4283-4303
Open Access | Times Cited: 51
DAT and TH expression marks human Parkinson’s disease in peripheral immune cells
Adithya Gopinath, Phillip Mackie, Basil Hashimi, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 32
The single-cell opioid responses in the context of HIV (SCORCH) consortium
Seth A. Ament, Rianne R. Campbell, Mary Kay Lobo, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3950-3961
Open Access | Times Cited: 6
Sleep disturbances in HIV infection and their biological basis
Katie O'Brien, Natalie E. Riddell, F. Xavier Gómez‐Olivé, et al.
Sleep Medicine Reviews (2021) Vol. 65, pp. 101571-101571
Open Access | Times Cited: 35
Advancing the preclinical study of comorbid neuroHIV and substance use disorders: Current perspectives and future directions
Mark D. Namba, Qiaowei Xie, Jacqueline M. Barker
Brain Behavior and Immunity (2023) Vol. 113, pp. 453-475
Open Access | Times Cited: 13
Transcriptional impacts of substance use disorder and HIV on human ventral midbrain neurons and microglia
A. Wilson, Michelle M. Jacobs, Tova Y. Lambert, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Co-receptor signaling in the pathogenesis of neuroHIV
Emily Nickoloff-Bybel, Lindsay Festa, Olimpia Meucci, et al.
Retrovirology (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 25
Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
Xiaolei Zhu, Kristen R. Hollinger, Yiyao Huang, et al.
Neurobiology of Disease (2022) Vol. 169, pp. 105734-105734
Open Access | Times Cited: 16
Dynamics of Plasmatic Levels of Pro- and Anti-Inflammatory Cytokines in HIV-Infected Individuals with M. tuberculosis Co-Infection
Marina Nosik, Konstantin Ryzhov, I. Rymanova, et al.
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2291-2291
Open Access | Times Cited: 22
Neuropathogenesis of HIV-1: insights from across the spectrum of acute through long-term treated infection
Lauren Killingsworth, Serena Spudich
Seminars in Immunopathology (2022) Vol. 44, Iss. 5, pp. 709-724
Open Access | Times Cited: 15
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat
Alexis F. League, Benjamin L. Gorman, Douglas J. Hermes, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 16
Central Nervous System Impact of Perinatally Acquired HIV in Adolescents and Adults: an Update
Sharon Nichols
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 1, pp. 121-132
Open Access | Times Cited: 11
Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders
Nikolai Fattakhov, Silvia Torices, Michael Stangis, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1883-1883
Open Access | Times Cited: 15
Human iPSC-derived brain organoids: A 3D mini-brain model for studying HIV infection
Zhengyu Wei, Brittany Bodnar, Ruo-Tong Zhao, et al.
Experimental Neurology (2023) Vol. 364, pp. 114386-114386
Open Access | Times Cited: 6
Deprenyl reduces inflammation during acute SIV infection
Katy Emanuel, Kaitlyn Runner, Zachary D. Brodnik, et al.
iScience (2022) Vol. 25, Iss. 5, pp. 104207-104207
Open Access | Times Cited: 8
Glutamine antagonist JHU083 improves psychosocial behavior and sleep deficits in EcoHIV-infected mice
Benjamin J. Bell, Kristen R. Hollinger, Pragney Deme, et al.
Brain Behavior & Immunity - Health (2022) Vol. 23, pp. 100478-100478
Open Access | Times Cited: 7
Dopaminergic inhibition of human neutrophils is exerted through D1‐like receptors and affected by bacterial infection
Franca Marino, Monica Pinoli, Emanuela Rasini, et al.
Immunology (2022) Vol. 167, Iss. 4, pp. 508-527
Open Access | Times Cited: 6
Cortico-striatal networking deficits associated with advanced HIV disease and cocaine use
Kareem Al‐Khalil, Ryan P. Bell, Sheri L. Towe, et al.
Journal of NeuroVirology (2023) Vol. 29, Iss. 2, pp. 167-179
Open Access | Times Cited: 3
Astrocytes: Role in pathogenesis and effect of commonly misused drugs in the HIV infected brain
Jessalyn Pla-Tenorio, Angela M. Roig, Paulina A. García-Cesaní, et al.
Current Research in Neurobiology (2023) Vol. 5, pp. 100108-100108
Open Access | Times Cited: 3
Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis
Liana Basova, Alexander Lindsey, Anne Marie McGovern, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 544-544
Open Access | Times Cited: 7
Red Algal Sulfated Galactan Binds and Protects Neural Cells from HIV-1 gp120 and Tat
Vitor H. Pomin, Fakhri Mahdi, Weihua Jin, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 714-714
Open Access | Times Cited: 6
Longitudinal changes in neurocognitive performance related to drug use intensity in a sample of persons with and without HIV who use illicit stimulants
Sheri L. Towe, Runshi Tang, Matthew Gibson, et al.
Drug and Alcohol Dependence (2023) Vol. 251, pp. 110923-110923
Closed Access | Times Cited: 2
A “Drug-Dependent” Immune System Can Compromise Protection against Infection: The Relationships between Psychostimulants and HIV
María Amparo Assis, Pedro G. Carranza, Emilio Ambrosio
Viruses (2021) Vol. 13, Iss. 5, pp. 722-722
Open Access | Times Cited: 5
Sleep Disorders and Challenges in People Living with Human Immunodeficiency Virus: A Narrative Literature Review
Lourdes M. DelRosso, Deacon Yang, Muhammad Shoaib Khan, et al.
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 217-225
Closed Access
Page 1 - Next Page

Scroll to top